Structural significance of azaheterocyclic amines related to Parkinson's disease for dopamine transporter (Q47894341)

6 February 2018

title

Structural significance of azaheterocyclic amines related to Parkinson's disease for dopamine transporter (English)

1 reference

6 February 2018

1 reference

Matsubara K

1

1 reference

6 February 2018

Senda T

2

1 reference

6 February 2018

Uezono T

3

1 reference

6 February 2018

Fukushima S

4

1 reference

6 February 2018

Ohta S

5

1 reference

6 February 2018

Igarashi K

6

1 reference

6 February 2018

Naoi M

7

1 reference

6 February 2018

Yamashita Y

8

1 reference

6 February 2018

Ohtaki K

9

1 reference

6 February 2018

Hayase N

10

1 reference

6 February 2018

Akutsu S

11

1 reference

6 February 2018

Kimura K

12

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 May 1998

1 reference

6 February 2018

European Journal of Pharmacology

published in

1 reference

6 February 2018

volume

348

1 reference

6 February 2018

issue

1

1 reference

6 February 2018

page(s)

77-84

1 reference

6 February 2018

The dopamine inhibitor GBR 12909: selectivity and molecular mechanism of action

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900131-9

Intracerebral microdialysis neurotoxicity studies of quinoline and isoquinoline derivatives related to MPTP/MPP+.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900131-9

Implication of dopamine transporter system on 1-methyl-4-phenylpyridinium and rotenone effect in striatal synaptosomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900131-9

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900131-9

Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900131-9

Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900131-9

Indole-N-methylated β-carbolinium ions as potential brain-bioactivated neurotoxins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900131-9

Dopamine uptake inhibitory capacities of beta-carboline and 3,4-dihydro-beta-carboline analogs of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) oxidation products.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900131-9

The MPTP-treated mouse as a model of parkinsonism: how good is it?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900131-9

The conformation of dopamine at its uptake site; further studies with rigid analogues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900131-9

Effect of a pyridinium metabolite derived from haloperidol on the activities of striatal tyrosine hydroxylase in freely moving rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900131-9

Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900131-9

Novel endogenous 1,2,3,4-tetrahydroisoquinoline derivatives: uptake by dopamine transporter and activity to induce parkinsonism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900131-9

Tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline as novel endogenous amines in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900131-9

1‐Benzyl‐1,2,3,4‐Tetrahydroisoquinoline as a Parkinsonism‐Inducing Agent: A Novel Endogenous Amine in Mouse Brain and Parkinsonian CSF

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900131-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900131-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900131-9

Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900131-9

N-methylation of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, (R)-salsolinol, in rat brains: in vivo microdialysis study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900131-9

A dopaminergic neurotoxin, (R)-N-methylsalsolinol, increases in parkinsonian cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900131-9

Mono-N-methylation of 1,2,3,4-tetrahydro-beta-carbolines in brain cytosol: absence of indole methylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900131-9

Novel S-adenosylmethionine-dependent indole-N-methylation of beta-carbolines in brain particulate fractions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900131-9

beta-Carbolinium cations, endogenous MPP+ analogs, in the lumbar cerebrospinal fluid of patients with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900131-9

Differences in dopamine efflux induced by MPP+ and beta-carbolinium in the striatum of conscious rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900131-9

Inhibition of [3H]dopamine uptake into striatal synaptosomes by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900131-9

A N-methyltransferase in human brain catalyses N-methylation of 1,2,3,4-tetrahydroisoquinoline into N-methyl-1,2,3,4-tetrahydroisoquinoline, a precursor of a dopaminergic neurotoxin, N-methylisoquinolinium ion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900131-9

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900131-9

Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900131-9

In vivo intracerebral microdialysis studies in rats of MPP+ analogues and related charged species.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900131-9

Identification of potentially neurotoxic pyridinium metabolite in the urine of schizophrenic patients treated with haloperidol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900131-9

Inhibition of mitochondrial respiration by 1,2,3,4-tetrahydroisoquinoline-like endogenous alkaloids in mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900131-9

Uptake of a neurotoxin-candidate, (R)-1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline into human dopaminergic neuroblastoma SH-SY5Y cells by dopamine transport system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900131-9

(+)MK-801 prevents the DDC-induced enhancement of MPTP toxicity in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900131-9

Striatal transporter for dopamine: catechol structure-activity studies and susceptibility to chemical modification.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900131-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(98)00131-9

1 reference

6 February 2018

PubMed ID

9650834

1 reference

6 February 2018